Paper210361
Biologic and immunologic activities and applications of somatostatin analogs.
Vale W and 3 others. Metabolism, 1978. Cited by 186 papers, by iCite.
Cite this record
ConductScience Library. Biologic and immunologic activities and applications of somatostatin analogs. Papers, record 210361. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/210361
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Somatostatin | Major topic |
| Animals | |
| Glucagon | |
| Growth Hormone | |
| Insulin | |
| Insulin Secretion | |
| Male | |
| Rats | |
| Receptors, Cell Surface | |
| Structure-Activity Relationship |
Source PubMed
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 186 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33282845 | In vitro Targetability Validation of Peptide-Functionalized Mesoporous Silica Nanoparticles in the Presence of Serum Proteins. | Front Chem | 2020 | https://conductscience.org/library/papers/33282845 | PubMed |
| 32309597 | Functional Amyloids and their Possible Influence on Alzheimer Disease. | Discoveries (Craiova) | 2017 | https://conductscience.org/library/papers/32309597 | PubMed |
| 31436539 | Understanding Peptide Binding in Class A G Protein-Coupled Receptors. | Mol Pharmacol | 2019 | https://conductscience.org/library/papers/31436539 | PubMed |
| 30148051 | Targeting Somatostatin Receptors By Functionalized Mesoporous Silica Nanoparticles - Are We Striking Home? | Nanotheranostics | 2018 | https://conductscience.org/library/papers/30148051 | PubMed |
| 27942815 | Neuropeptides: Central nervous system effects on nutrient metabolism. | Diabetologia | 1981 | https://conductscience.org/library/papers/27942815 | PubMed |
| 27408771 | Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets. | Mol Metab | 2016 | https://conductscience.org/library/papers/27408771 | PubMed |
| 27271737 | Peptide aromatic interactions modulated by fluorinated residues: Synthesis, structure and biological activity of Somatostatin analogs containing 3-(3',5'difluorophenyl)-alanine. | Sci Rep | 2016 | https://conductscience.org/library/papers/27271737 | PubMed |
| 26076035 | Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. | Nat Med | 2015 | https://conductscience.org/library/papers/26076035 | PubMed |
| 25749472 | Cancer stratification by molecular imaging. | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/25749472 | PubMed |
| 25663834 | Somatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and Therapeutics. | J Lung Cancer | 2011 | https://conductscience.org/library/papers/25663834 | PubMed |
| 23320604 | Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study. | J Transl Med | 2013 | https://conductscience.org/library/papers/23320604 | PubMed |
| 23193953 | Membrane-displayed somatostatin activates somatostatin receptor subtype-2 heterologously produced in Saccharomyces cerevisiae. | AMB Express | 2012 | https://conductscience.org/library/papers/23193953 | PubMed |
| 19624154 | The beta-D-glucose scaffold as a beta-turn mimetic. | Acc Chem Res | 2009 | https://conductscience.org/library/papers/19624154 | PubMed |
| 18410084 | Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity. | J Med Chem | 2008 | https://conductscience.org/library/papers/18410084 | PubMed |
| 16854054 | Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR. | J Med Chem | 2006 | https://conductscience.org/library/papers/16854054 | PubMed |
| 16311415 | Treatment of pituitary tumors: somatostatin. | Endocrine | 2005 | https://conductscience.org/library/papers/16311415 | PubMed |
| 11081159 | Development of pituitary adenoma treatment--a critical essay. | Pituitary | 1999 | https://conductscience.org/library/papers/11081159 | PubMed |
| 8287633 | Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8287633 | PubMed |
| 7911441 | Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. | Gut | 1994 | https://conductscience.org/library/papers/7911441 | PubMed |
| 6150052 | Suppression and stimulation of growth hormone release in sheep by somatostatin analogs. | J Endocrinol Invest | 1984 | https://conductscience.org/library/papers/6150052 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/210361
GET https://conductscience.org/api/papers/v1/210361/cited_by?page=2